Infectious Disease Specialists of Atlanta
Decatur, Georgia, United States
Infectious disease physician in North Decatur, Georgia
2665 N Decatur Rd, Decatur, GA 30033
About Infectious Disease Specialists of Atlanta
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
30
Bristol-Myers Squibb
2
ViiV Healthcare
2
GlaxoSmithKline
1
Hoffmann-La Roche
1
MiMedx Group, Inc.
1
Summit Therapeutics
1
Triangle Pharmaceuticals
1
Clinical Trials at Infectious Disease Specialists of Atlanta
During the past decade, Infectious Disease Specialists of Atlanta conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 17 clinical trials were completed, i.e. on
average, 170% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
Completed
825
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
1999-12-01
2002-01-01
Completed
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
2000-08-01
Unknown status
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
2001-02-01
Unknown status
400
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
2001-02-01
2003-09-01
Completed
Expanded Access Program for Maraviroc At Multiple Centers
2007-02-01
2010-06-01
Completed
1,047
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
2008-07-01
2015-04-01
Completed
724
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2009-04-01
2013-09-01
Completed
71
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Infectious Disease Specialists of Atlanta" #1 sponsor was "Gilead Sciences" with 30 trials, followed by "Bristol-Myers Squibb" with 2 trials
sponsored, "ViiV Healthcare" with 2 trials sponsored, "GlaxoSmithKline" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Disease Specialists of Atlanta"
#1 collaborator was "Janssen Research & Development, LLC" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Infectious Disease Specialists of Atlanta
According to Clinical.Site data, the most researched conditions in "Infectious Disease Specialists of Atlanta" are
"HIV Infections" (19 trials), "HIV-1 Infection" (8 trials), "HIV" (7 trials), "Acquired Immunodeficiency Syndrome" (6 trials) and "Hepatitis C, Chronic" (4 trials). Many other conditions were trialed in "Infectious Disease Specialists of Atlanta" in a lesser frequency.
Clinical Trials Intervention Types at Infectious Disease Specialists of Atlanta
Most popular intervention types in "Infectious Disease Specialists of Atlanta" are "Drug" (36 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "E/C/F/TAF" (7 trials), "B/F/TAF" (6 trials), "COBI" (6 trials), "E/C/F/TDF" (6 trials) and "FTC/TDF" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Infectious Disease Specialists of Atlanta
The vast majority of trials in "Infectious Disease Specialists of Atlanta" are
38 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Infectious Disease Specialists of Atlanta
Currently, there are NaN active trials in "Infectious Disease Specialists of Atlanta".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in Infectious Disease Specialists of Atlanta,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Infectious Disease Specialists of Atlanta, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 25 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".